On Monday, Shares of Tableau Software Inc (NYSE:DATA), lost -4.96% to $94.80.
Tableau Software, declared the launch of its Shanghai operations (Tableau (China) Co., Ltd.) as the company expands in China to better serve customers and partners locally.
Tableau is on a mission to assist more people see and understand their data. The opening of its Shanghai office is a milestone in the company’s growth in China. JY Pook, APAC Vice President of Tableau Software said, “With 1.3 billion people, a quickly expanding urban economy, and exponential rates of Internet and smartphone penetration, China generates an immense amount of data annually. Tableau can assist bring that data to life with rapid-fire insights.”
With greater use of data in different industries, China’s business analytics services market is set to maintain accelerated growth, and raising the momentum of tech investments for the rest of APAC. The country’s 2015 Government Work Report said that China will develop an ‘Internet Plus’ action plan to step up the integration of mobile Internet, cloud computing, big data, and the Internet of Things with modern manufacturing, e-commerce, industrial Internet and Internet finance. Analysts report that China’s business analytics services market reached US$1.398 billion in 2014, up 16.4 per cent from 2013. The space is forecast to grow steadily at the CAGR of 16.7 per cent in the coming five years to reach US$3.027 billion in 2019.
Tableau Software, Inc., together with its auxiliaries, provides business analytics software products in the United States, Canada, and internationally. The company offers Tableau Desktop, a self-service analytics environment that empowers people to access and analyze data independently; and Tableau Server, a business intelligence platform with data administration, scalability, and security to foster the sharing of data, in addition to to improve the dissemination of information in an organization and promote improved decision-making.
Shares of Finisar Corporation (NASDAQ:FNSR), declined -3.78% to $14.75, during its last trading session.
Finisar Corporation (FNSR), a global technology leader in high-speed optical communications, confirmed that it will declare its fiscal first quarter 2016 financial results for the period ending August 2, 2015, at the close of market on Thursday, September 10th, 2015. The declaration will be followed by a conference call with analysts at 2:00 p.m. PDT/ 5:00 p.m. EDT.
Jerry Rawls, Finisar Corporation’s executive Chairman of the Board; Eitan Gertel, Chief Executive Officer; and Kurt Adzema, Chief Financial Officer, will talk about financial results for the quarter and answer questions from analysts who follow the Company.
Finisar Corporation provides optical subsystems and components for data communication and telecommunication applications in the United States, Malaysia, China, and internationally.
At the end of Monday’s trade, Shares of Norwegian Cruise Line Holdings Ltd (NASDAQ:NCLH), lost -2.09% to $54.93.
Norwegian Cruise Line Holdings Ltd., declared the pricing of the formerly declared secondary public offering of 20 million of its ordinary shares by certain funds associated with Apollo Global Administration, LLC, Star NCLC Holdings Ltd. and certain funds associated with TPG Global, LLC following an automatic shelf registration statement on Form S-3 filed with the U.S. Securities and Exchange Commission at a price to the public of $59.25 per ordinary share. The offering is predictable to close on or about August 13, 2015, subject to customary closing conditions.
Norwegian did not sell any ordinary shares in the offering and will not receive any of the proceeds from the offering. The total number of Norwegian ordinary shares outstanding will not change as a result of the offering.
Norwegian Cruise Line Holdings Ltd., a cruise line operator, through its auxiliaries, provides cruise experiences for travelers with various itineraries. It offers cruises ranging from 1 day to 180 days.
Finally, BioScrip Inc (NASDAQ:BIOS), ended its last trade with 5.98% gain, and closed at $1.95.
BioScrip, declared the expiration of the subscription period for its formerly declared rights offering of subscription rights to purchase units comprising of Series A convertible preferred stock, Class A warrants, each to purchase one share of common stock at a price of $5.17 per share, and Class B warrants, each to purchase one share of common stock at a price of $6.45 per share.
The subscription period expired at 5:00 p.m., New York City time, on July 27, 2015. Based on results received from American Stock Transfer & Trust Company, LLC (“AST”), the subscription agent for the rights offering, stockholders exercised subscription rights to purchase 10,822 units, comprising of 10,822 shares of the Series A convertible preferred stock, 31,025 Class A warrants, and 31,025 Class B warrants, at a subscription price of $100.00 per unit. BioScrip estimates that it will receive about $1,082,200 in aggregate gross proceeds from the consummation of the rights offering.
Rights that were not properly exercised by 5:00 p.m., New York City time, on July 27, 2015, have expired and are no longer exercisable. The shares of Series A convertible preferred stock, Class A and Class B warrants will be distributed by AST by way of direct registration in book-entry form or through the facilities of The Depository Trust Company, as applicable, on or about July 31, 2015.
BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit administration (PBM) services in the United States. It operates in two segments, Infusion Services and PBM Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
